Savara Inc Current Assets
Savara Inc (SVRA) had Current Assets of $178.32 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-11
- 2026-06-30: Assets, Current $178.32M.
- 2026-03-31: Assets, Current $209.26M.
- 2025-12-31: Assets, Current $241.62M.
- 2025-09-30: Assets, Current $128.20M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $178.32M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $209.26M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $241.62M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $128.20M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $150.99M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $177.44M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $202.13M 10-K · filed 2026-03-13 | |
| 2024-09-30 | $226.40M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $127.69M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $146.19M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $165.95M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $170.10M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $107.90M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $117.63M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $128.95M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $137.07M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $145.38M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $154.54M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $165.00M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $174.58M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $183.49M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $194.80M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $85.12M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $96.33M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $102.56M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $107.44M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $124.07M 10-K · filed 2021-03-10 | |
| 2019-09-30 | $108.35M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $114.17M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $107.52M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $113.34M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $114.75M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $77.44M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $87.57M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $97.86M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $55.52M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $63.67M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $8.16M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $14.61M 10-K · filed 2018-03-14 | $12.19M 10-K · filed 2017-03-06 |
| 2016-09-30 | $28.28M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $35.82M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $38.25M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $42.25M 10-K · filed 2017-03-06 | |
| 2015-09-30 | $51.45M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $44.75M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $50.56M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $58.40M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $44.06M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $47.56M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $50.61M 10-Q · filed 2014-05-05 | |
| 2013-12-31 | $45.53M 10-K · filed 2015-03-24 | $45.53M 10-K · filed 2014-03-26 |
| 2013-09-30 | $49.93M 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $54.12M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $32.53M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $37.17M 10-K · filed 2014-03-26 | |
| 2012-09-30 | $41.64M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $44.29M 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $47.31M 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $51.79M 10-K · filed 2013-03-19 | |
| 2011-09-30 | $39.04M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $42.73M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $28.41M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |